Maxime De Laere

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration

Barbara Willekens, Silvia Presas‐Rodríguez, MJ Mansilla et al. · BMJ Open · 2019 · 97 citations · Full text

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA

Judith Derdelinckx, María José Mansilla, Maxime De Laere et al. · Journal of Neuroinflammation · 2019 · 30 citations · Full text

Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood–Brain Barrier under Inflammatory Conditions In Vitro

Maxime De Laere, Carmelita Pestana Sousa, Megha Meena et al. · Mediators of Inflammation · 2017 · 19 citations · Full text

Immunology, Immune Regulation, Immunologic Mechanism +23

A Microfluidic In Vitro Three-Dimensional Dynamic Model of the Blood–Brain Barrier to Study the Transmigration of Immune Cells

Megha Meena, Robin Vandormael, Maxime De Laere et al. · Brain Sciences · 2022 · 18 citations · Full text

Engineering, Immune Regulation, Immunology +24

Shuttling Tolerogenic Dendritic Cells across the Blood–Brain Barrier In Vitro via the Introduction of De Novo C–C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation

Maxime De Laere, Judith Derdelinckx, Mari Hassi et al. · Frontiers in Immunology · 2018 · 13 citations · Full text